Login to Your Account

Window Will Remain Open for Awhile

Even in a Heated Market IPO Isn't for Every Biotech

By Brian Orelli
Contributing Writer

Monday, August 5, 2013

With 23 U.S. biotechs going public on U.S. exchanges so far this year, compared to just 11 initial public offerings (IPOs) all of last year, the IPO window is starting to look more like an IPO bubble.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription